Clinical trial investigators database

How can I get started? Create a Profile There is no charge to investigators or their institutions to opt-in to the Investigator Databank and to create a profile. What are the benefits to industry? Member pharma companies benefit from the following: More informed protocol planning and country selection Increased access to investigators for feasibility and site identification More rapid recruitment through better matching of investigators to protocols Faster start-up from sharing of standard documents.

The template can be downloaded as an MS Word file for adaptation by the study investigator. It operationalizes the study protocol and describes each step of the study and how it is to be executed. Ideally, the MOP would contain an adequate amount of detail that any individual s at any site s could run the study consistently with only the information contained in the MOP and its appendices. Investigators with a multi-site study are required to submit a MOP, while single-site study investigators are strongly encouraged to review the MOP and determine which sections are necessary in order to ensure the study procedures are performed as intended.

The Guidelines below provide details on each section of the MOP, while the MOP Outlines are an overview listing the sections that are most relevant in those types of studies. The consent process provides individuals with sufficient information for making informed decisions about participation in a clinical research study.

The following documents are provided as a tool to assist NIA investigators for developing a comprehensive informed consent:. Yemen Zambia Zimbabwe x. City x. Distance 50 miles miles miles miles. Advanced Search. Researchers Search the database to stay up to date on developments in your field, find collaborators, and identify unmet needs. We view this as an integral part of the scientific process. Therefore, we ask that you identify the specific areas of expertise that you may have.

We empower study participants through informed decisions regarding study participation.